| |
| |
|
| Insider
Information: |
Cummings Keith Lamont |
| Relationship: |
Chief Financial Officer |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
271,713 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
271,713 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Pliant Therapeutics, Inc. |
PLRX |
Chief Financial Officer |
2024-05-02 |
271,713 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
21 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PLRX |
Pliant Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2024-05-02 |
4 |
OE |
$2.08 |
$43,680 |
D/D |
21,000 |
271,713 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2024-01-23 |
4 |
A |
$0.00 |
$0 |
D/D |
55,250 |
249,855 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2024-01-17 |
4 |
AS |
$17.23 |
$168,527 |
D/D |
(9,781) |
194,605 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2023-07-17 |
4 |
AS |
$18.01 |
$356,058 |
D/D |
(19,771) |
203,999 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2023-07-14 |
4 |
A |
$0.00 |
$0 |
D/D |
38,750 |
223,770 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2023-06-13 |
4 |
OE |
$2.08 |
$63,960 |
D/D |
30,750 |
185,020 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2023-06-09 |
4 |
OE |
$2.08 |
$12,064 |
D/D |
5,800 |
154,270 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
Chief Financial Officer |
• • – |
2023-01-25 |
4 |
A |
$0.00 |
$0 |
D/D |
54,000 |
138,424 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
Chief Financial Officer |
• • – |
2023-01-23 |
4 |
AS |
$35.00 |
$1,050,000 |
D/D |
(30,000) |
84,424 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
Chief Financial Officer |
• • – |
2023-01-23 |
4 |
OE |
$2.08 |
$134,850 |
D/D |
30,000 |
114,424 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
Chief Financial Officer |
• • – |
2022-12-22 |
4 |
OE |
$2.08 |
$8,320 |
D/D |
4,000 |
84,424 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
Chief Financial Officer |
• • – |
2022-12-20 |
4 |
S |
$19.10 |
$184,204 |
D/D |
(9,643) |
80,424 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
Chief Financial Officer |
• • – |
2022-12-19 |
4 |
A |
$0.00 |
$0 |
D/D |
19,375 |
90,067 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2021-09-03 |
4 |
OE |
$2.08 |
$41,600 |
D/D |
20,000 |
67,621 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2021-03-05 |
4 |
OE |
$2.08 |
$41,600 |
D/D |
20,000 |
47,621 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2020-12-21 |
4 |
OE |
$2.08 |
$9,360 |
D/D |
4,500 |
27,621 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2020-12-01 |
4 |
OE |
$2.08 |
$68,539 |
D/D |
18,734 |
41,855 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2020-12-01 |
4 |
AS |
$28.24 |
$562,035 |
D/D |
(18,734) |
23,121 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2020-06-05 |
4 |
A |
$0.00 |
$0 |
D/D |
3,821 |
23,121 |
0 |
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
Chief Financial OfficerOfficer |
• – – |
2020-06-02 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
19,300 |
|
- |
|
| PLRX |
Pliant Therapeutics, Inc. |
Chief Financial Officer |
• – – |
2020-04-30 |
4 |
OE |
$2.08 |
$40,144 |
D/D |
19,300 |
19,300 |
0 |
- |
|
21 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
